Healius share price soars 20% on news of $500 million sale

The Healius share price is up more than 20% today after it announced the $500 million sale of its medical centres business.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Healius Ltd (ASX: HLS) share price is up by 20.36% at the time of writing, following a market update this morning announcing the sale of its medical centres. 

What's moving the Healius share price?

The company announced the sale of Healius Primary Care, its medical centres business, to BGH Capital for $500 million. The proceeds will be used for investments and to pay down debt.

Commenting on the sale, Healius managing director and CEO, Dr Malcolm Parmenter said:

This sale is consistent with our strategy of simplifying our portfolio and focusing on our leading and scalable diagnostics and day hospital business, in order to deliver on our mission of seeking and sustaining life-enhancing healthcare through people who care.

The proceeds will strengthen the company, reducing our net debt and freeing up capital for investment, while enabling shareholders to realise the value of the Medical Centres business, which has not been reflected in our share price.

Healius expects to receive a total of $470 million from the sale after costs. The transaction is expected to be completed by the end of 2020 and will be subject to approval by the foreign investment review board.

The company also announced that it has seen growth in its diagnostics business since the economy started to reopen following shutdowns. This has been supported by testing for the coronavirus in its pathology labs. Healius announced that its day hospitals, dental and IVF businesses were also moving back toward pre-coronavirus levels following the lifting of restrictions.

How has the Healius share price performed in 2020?

The Healius share price is up 58.33% since its 52-week low reached in April. The company's share price performance for the year to date has been steady, rising 10.14% since the beginning of January. The Healius share price has fallen 4.10% since this time in 2019, but is now significantly closer to its 52-week high of $3.32. 

Motley Fool contributor Chris Chitty has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Silhouettes of nine people climbing a steep mountain to the top at sunset, and helping each other along the way.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a wild ride this Thursday.

Read more »

Two men in hard hats and high visibility jackets look together at a laptop screen at a mine site.
Gold

Down 50% in a year, time to pounce on this beaten-down ASX 200 gold stock?

A leading expert offers his verdict on this beaten-down ASX 200 gold miner.

Read more »

A view of competitors in a running event, some wearing number bibs, line up together on a starting line looking ahead as if to start a race.
Best Shares

Best ASX 200 share of each market sector in FY25

Did you own any of these ASX 200 winners in FY25?

Read more »

children and teacher in childcare education setting
Broker Notes

Why did Macquarie just re-rate G8 Education shares?

G8 Education shares are down 23% this year.

Read more »

IPO written in yellow and stuck in the air.
IPOs

End of the IPO drought: GemLife listing one of the biggest of the year

The GemLife IPO is the third major ASX listing in less than a month.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Share Market News

Why brokers says these ASX dividend stocks are top buys for income investors

Want an income boost? Take a look at these stocks that brokers rate as buys.

Read more »

A man looking at his laptop and thinking.
Broker Notes

After crashing more than 21% yesterday, does Macquarie rate Helia shares a buy?

Should I buy the big dip on Helia shares? Here’s Macquarie’s latest share price forecast.

Read more »

Happy work colleagues give each other a fist pump.
Broker Notes

Buy this ASX 200 share that is having a 'milestone year'

Bell Potter has good things to say about this high-flying stock.

Read more »